Clinuvel Pharmaceut. (ASX:CUV)

Last updated

Previous Close
Day Range
Year Range
Market Cap
Volume
P/E
44.58
Historical Yield (%)
0.11
Short Sell (%)
5.62
GICS Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
GICS Sub-Industry Group
Biotechnology - 35201010
EPS
50.00
ROE (%)
0.29
ROA (%)
0.19
EBITDA Margin (%)
0.60
EBIT Margin (%)
0.59
NPAT Margin (%)
0.52
Inventory Turnover
3.03
Asset Turnover
0.50
Net Gearing (%)
0.01
Net Interest Cover
17.44
Current Ratio
11.81

About Clinuvel Pharmaceut. (CUV.AX)

Research & News

  • 27 Stocks on the ASX 200 To Watch This Week [30 Aug 2021] August 30, 2021 - The ASX ended the week just scraping by into the green as the reporting season neared its end amidst continuing damage from the delta variant. The ASX200, ASX300, and Ordinaries ended the week up 0.3%, 0.34%, and 0.4% respectively. As Australian markets closed Friday, all eyes were on the Jackson Hole Symposium in progress in… Continue Reading

Are you looking for the best stocks to buy in 2021? We’ve put together a free report on 5 stocks that we think are the best buys on the ASX right now. Download it instantly here.

 

Information is provided ‘as is’ and solely for information purposes, not for trading purposes or advice.

Subscribe

Want more Free Research?

Subscribe today for free and get an alert when we have new research and webinars.

Invalid email address
We promise not to spam you. You can unsubscribe at any time.

MF & Co. Asset Management

MF & Co. Asset Management is a boutique investment firm offering Equity Capital Markets and derivative general advice & trade execution services.

We are specialists in advising and trading in Australian and US Equities, Index & Equity Options and Options on Futures.

Contact

Get In Touch

Australia
1300 889 603
International
+61 2 8378 7199
M-F: 8am-5pm

Suite 803, Level 8
70 Pitt St, Sydney, NSW 2000

 

Share This